DrugPatentWatch Database Preview
Details for New Drug Application (NDA): 081298
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
NDA 081298 describes CHLORZOXAZONE, which is a drug marketed by Actavis Elizabeth, Aurolife Pharma Llc, Barr, Mikart, Novitium Pharma, Ohm Labs, Par Pharm, Pioneer Pharms, Sun Pharm Industries, and Watson Labs, and is included in twenty NDAs. It is available from sixteen suppliers. Additional details are available on the CHLORZOXAZONE profile page.
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are sixteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
The generic ingredient in CHLORZOXAZONE is chlorzoxazone. There are sixteen drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the chlorzoxazone profile page.
Summary for 081298
| Tradename: | CHLORZOXAZONE |
| Applicant: | Ohm Labs |
| Ingredient: | chlorzoxazone |
| Patents: | 0 |
| Formulation / Manufacturing: | see details |
Medical Subject Heading (MeSH) Categories for 081298
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 250MG | ||||
| Approval Date: | Dec 29, 1993 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
